Endoluminal brachytherapy for recurrent laryngeal carcinoma

The role of high‐dose‐rate and pulsed‐dose‐rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy

“…The method was described to be well tolerated and effective in relieving the symptoms related to the disease. Latham et al 4 present the management of a 54-year-old man with multiple recurrences from a squamous cell carcinoma of the larynx. The dose given was 25 Gy at 5 mm over 25.2 h, and was achieved with minimal early or delayed sideeffects.…”

“…Treatment can often only be of a symptomatic and palliative nature. [4][5][6] Brachytherapy constitutes a method that has gained actuality in the treatment of recurrent or advanced head-and-neck-cancers. Derived from ancient Greek words for short distance (brachios) and treatment (therapy), it refers to the therapeutic use of encapsulated radionuclides placed within or close to a tumor.…”

“…The management of stomal recurrence including chemotherapy, external beam radiation therapy (EBRT), and surgery has been reported as unsatisfactory. Treatment can often only be of a symptomatic and palliative nature 4–6…”